Anti-glomerular basement membrane antibody mediated disease (Q44664): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(One intermediate revision by the same user not shown)
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: N08.8 / rank
 
Normal rank

Latest revision as of 12:14, 13 August 2026

Anti-GBM mediated glomerulonephritis is an aggressive focal and segmental proliferative glomerular disease characterised by linear staining of the glomerular basement membrane for immunoglobulins, particularly IgG and IgM. Crescentic change is often associated and circulating anti-bodies to glomerular basement membrane are found in active disease. The renal syndrome is often acute nephritis with rapid renal functional decline (rapidly progressive nephritis) and if associated with respiratory involvement (haemoptysis, respiratory failure) the couple is termed “Goodpasture's syndrome”.
Language Label Description Also known as
default for all languages
MF85
    English
    Anti-glomerular basement membrane antibody mediated disease
    Anti-GBM mediated glomerulonephritis is an aggressive focal and segmental proliferative glomerular disease characterised by linear staining of the glomerular basement membrane for immunoglobulins, particularly IgG and IgM. Crescentic change is often associated and circulating anti-bodies to glomerular basement membrane are found in active disease. The renal syndrome is often acute nephritis with rapid renal functional decline (rapidly progressive nephritis) and if associated with respiratory involvement (haemoptysis, respiratory failure) the couple is termed “Goodpasture's syndrome”.

      Statements

      CID11:MF85
      0 references
      dki-india-MF85
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references